Journal List > Korean J Lab Med > v.27(5) > 1011425

Nah and Kim: Comparison of Cardiovascular Risk Factors between Normotension and Prehypertension

Abstract

Background

The individuals with prehypertension are known to progress to hypertension, one of the risk factors of cardiovascular disease, more readily than the group of normal blood pressure. This study was performed to investigate the differences in the risk factors of cardiovascular disease between normotensive and prehypertensive groups, and to identify the determinants of prehypertension.

Methods

Normotensive (N=3,732) and prehypertensive individuals (N=676) were selected from the people who underwent routine medical checkups at the Health Promotion Center (Seoul, Korea). The age, body mass index (BMI), fasting blood glucose, total cholesterol, triglyceride, LDL-cholesterol (C), HDL-C, high sensitivity C-reactive protein (hsCRP), lipoprotein(a) [Lp(a)], and the number of white blood cell were compared between the normotensive and prehypertensive groups.

Results

The age, BMI, fasting blood glucose, triglyceride, and total cholesterol were higher in the males and females in the prehypertensive group than in the normotensive group. LDL-C, however, was higher and HDL-C was lower in the females in the prehypertensive group than in the normotensive group. The determinants of prehypertension were found to be age, BMI, and triglyceride.

Conclusions

There were differences in the risk factors of cardiovascular disease between the prehypertensive and normotensive groups.

REFERENCES

1.National Statistical Office. Major 5 causes of death by age, number of deaths and mortality rate: 1997-2000. http://www.kosis.kr. (Retrieved July 20,. 2005.
2.Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002. 360:1903–13.
3.Chobanian AV., Bakris GL., Black HR., Cushman WC., Green LA., Izzo JL Jr, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA. 2003. 289:2560–72.
crossref
4.Vasan RS., Larson MG., Leip EP., Kannel WB., Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet. 2001. 358:1682–6.
crossref
5.The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997. 157:2413–46.
6.Vasan RS., Larson MG., Leip EP., Evans JC., O'Donnell CJ., Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001. 345:1291–7.
crossref
7.Tsai PS., Ke TL., Huang CJ., Tsai JC., Chen PL., Wang SY, et al. Prevalence and determinants of prehypertension status in the Taiwanese general population. J Hypertens. 2005. 23:1355–60.
crossref
8.Sorof J., Daniels S. Obesity hypertension in children: a problem of epidemic proportions. Hypertension. 2002. 40:441–7.
9.Marroquin OC., Kip KE., Kelley DE., Johnson BD., Shaw LJ., Bairey Merz CN, et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation. 2004. 109:714–21.
crossref
10.Liu L., Choudhury SR., Okayama A., Hayakawa T., Kita Y., Ueshima H. Changes in body mass index and its relationships to other cardiovascular risk factors among Japanese population: results from the 1980 and 1990 national cardiovascular surveys in Japan. J Epidemiol. 1999. 9:163–74.
crossref
11.Jousilathti P., Tuomilehto J., Vartianinen E., Pekkanen J., Puska P. Body weight, cardiovascular risk factors, and coronary mortality. 15-year follow-up of middle-aged men and women in eastern Finland. Circulation. 1996. 93:1372–9.
12.Muntner P., He J., Culter JA., Wildman RP., Whelton PK. Trends in blood pressure among children and adolescents. JAMA. 2004. 291:2107–13.
crossref
13.Israeli E., Schochat T., Korzets Z., Tekes-Manova D., Bernheim J., Golan E. Prehypertension and obesity in adolescents: a population study. Am J Hypertens. 2006. 19:708–12.
14.Lee JH., Hwang SY., Kim EJ., Kim MJ. Comparison of risk factors between prehypertension and hypertension in Korean male industrial workers. Public Health Nurs. 2006. 23:314–23.
crossref
15.Zhang Y., Lee ET., Devereux RB., Yeh J., Best LG., Fabsitz RR, et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension. 2006. 47:410–4.
16.Choi KM., Park HS., Han JH., Lee JS., Lee J., Ryu OH, et al. Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001. J Hypertens. 2006. 24:1515–21.
crossref
17.Grotto I., Grossman E., Huerta M., Sharabi Y. Prevalence of prehypertension and associated cardiovascular risk profiles among young Israeli adults. Hypertension. 2006. 48:254–9.
crossref
18.Chrysohoou C., Pitsavos C., Panagiotakos DB., Skoumas J., Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA Study. Am J Hypertens. 2004. 17:568–73.
19.Lee ZS., Critchley JA., Ko GT., Anderson PJ., Thomas GN., Young RP, et al. Obesity and cardiovascular risk factors in Hong Kong Chinese. Obes Rev. 2002. 3:173–82.
crossref

Table 1.
Comparison of clinical and metabolic characteristics by blood pressure status
  Normotension Prehypertension P value
Men (N=1,713) (N=419)  
 Systolic BP (mmHg) 106.2±8.0 124.8±6.2 <0.05
 Diastolic BP (mmHg) 68.0±5.9 77.3±5.6 <0.05
 Age (yr) 40.5±11.4 46.3±13.3 <0.05
 BMI 24.4±3.0 25.6±3.1 <0.05
 Fasting glucose (mg/dL) 95.0±18.1 99.7±22.0 <0.05
 Triglyceride (mg/dL) 127.3±78.0 149.4±100.4 <0.05
 T-cholesterol (mg/dL) 179.4±31.7 186.1±31.1 <0.05
 LDL-C (mg/dL) 114.3±29.0 117.4±28.3 NS
 HDL-C (mg/dL) 50.8±8.8 51.3±9.7 NS
 Lp(a) (mg/dL) 12.8±16.1 12.5±15.2 NS
 WBC (× 103 cells/L) 6.4±1.6 6.6±1.8 <0.05
 hsCRP (mg/dL) 0.169±0.512 0.167±0.323 NS
Women (N=2,019) (N=257)  
 Systolic BP (mmHg) 100.9±9.6 126.4±6.2 <0.05
 Diastolic BP (mmHg) 64.2±6.2 76.9±5.6 <0.05
 Age (yr) 39.4±11.0 52.9±11.8 <0.05
 BMI 22.3±3.0 24.4±3.1 <0.05
 Fasting glucose (mg/dL) 89.0±11.6 94.8±17.9 <0.05
 Triglyceride (mg/dL) 80.4±47.2 118.9±78.5 <0.05
 T-cholesterol (mg/dL) 172.4±30.8 192.6±39.0 <0.05
 LDL-C (mg/dL) 104.0±27.9 119.4±34.2 <0.05
 HDL-C (mg/dL) 57.2±10.1 55.8±9.4 <0.05
 Lp(a) (mg/dL) 15.2±17.8 16.2±20.3 NS
 WBC (× 103 cells/μL) 5.8±1.5 5.9±1.6 NS
 hsCRP (mg/dL) 0.109±0.345 0.155±0.456 NS

Abbreviations: BP, blood pressure; BMI, body mass index; T-cholesterol, total cholesterol; LDL-C, LDL-cholesterol; HDL-C, HDL-cholesterol; Lp(a), lipoprotein(a); WBC, white blood cell; hsCRP, high sensitivity C-reactive protein; NS, not significant.

Table 2.
Correlation coefficients between blood pressure and risk factors of cardiovascular disease
  r (Systolic BP/Diastolic BP) P value (Systolic BP/Diastolic BP)
Men    
 Age (yr) 0.244/0.164 0.000/0.000
 BMI 0.193/0.211 0.000/0.000
 Fasting glucose (mg/dL) 0.132/0.128 0.000/0.000
 T-cholesterol (mg/dL) 0.113/0.115 0.000/0.000
 Triglyceride (mg/dL) 0.110/0.135 0.000/0.000
 LDL-C (mg/dL) 0.067/0.067 0.000/0.002
 WBC (× 103 cells/μL) 0.056/0.069 0.008/0.001
Women    
 Age (yr) 0.487/0.418 0.000/0.000
 BMI 0.364/0.316 0.000/0.000
 Fasting glucose (mg/dL) 0.226/0.176 0.000/0.000
 T-cholesterol (mg/dL) 0.283/0.265 0.000/0.000
 Triglyceride (mg/dL) 0.282/0.252 0.000/0.000
 LDL-C (mg/dL) 0.252/0.238 0.000/0.000
 HDL-C (mg/dL) 0.051/0.042 0.014/0.043
 WBC (× 103 cells/μL) 0.071/0.057 0.001/0.006

Abbreviations: See Table 1.

Table 3.
Determinants of prehypertension from multivariable logistic regression model
  Variable Coefficient SE OR 95% CI of OR P value
Men Age (yr) 0.041 0.005 1.042 1.033-1.051 <0.001
  BMI 0.140 0.020 1.150 1.107-1.195 <0.001
  Triglyceride 0.001 0.001 1.001 1.000-1.003 0.020
Women Age (yr) 0.075 0.006 1.077 1.064-1.091 <0.001
  BMI 0.091 0.024 1.095 1.046-1.147 <0.001
  Triglyceride 0.004 0.001 1.004 1.002-1.006 <0.001

Abbreviations: SE, standard error; OR, odds ratio; CI, confidence interval; BMI, body mass index.

TOOLS
Similar articles